Skip to content

Clinical trials

Brain Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Country / region: United Kingdom Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20111
20122
20131
20145
20151
20164
20175
20182
20192
20225
20233
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated9
Recruiting6
Active, not recruiting5
Unknown status4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
AstraZeneca3
TauRx Therapeutics Ltd3
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
AC Immune SA2
GlaxoSmithKline2
Imperial College London2
NHS Greater Glasgow and Clyde2
University College, London2
University of Oxford2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases41
Central Nervous System Diseases23
Nervous System Diseases20
Alzheimer Disease17
Dementia17
Neurodegenerative Diseases14
Mental Disorders11
Neurocognitive Disorders9
Tauopathies8
Stroke6

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.